• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诱导性共刺激分子(ICOS)共刺激受体对T细胞活化和功能至关重要。

ICOS co-stimulatory receptor is essential for T-cell activation and function.

作者信息

Dong C, Juedes A E, Temann U A, Shresta S, Allison J P, Ruddle N H, Flavell R A

机构信息

Howard Hughes Medical Institute, Section of Immunobiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.

出版信息

Nature. 2001 Jan 4;409(6816):97-101. doi: 10.1038/35051100.

DOI:10.1038/35051100
PMID:11343121
Abstract

T-lymphocyte activation and immune function are regulated by co-stimulatory molecules. CD28, a receptor for B7 gene products, has a chief role in initiating T-cell immune responses. CTLA4, which binds B7 with a higher affinity, is induced after T-cell activation and is involved in downregulating T-cell responses. The inducible co-stimulatory molecule (ICOS), a third member of the CD28/CTLA4 family, is expressed on activated T cells. Its ligand B7H/B7RP-1 is expressed on B cells and in non-immune tissues after injection of lipopolysaccharide into animals. To understand the role of ICOS in T-cell activation and function, we generated and analysed ICOS-deficient mice. Here we show that T-cell activation and proliferation are defective in the absence of ICOS. In addition, ICOS -/- T cells fail to produce interleukin-4 when differentiated in vitro or when primed in vivo. ICOS is required for humoral immune responses after immunization with several antigens. ICOS-/- mice showed greatly enhanced susceptibility to experimental autoimmune encephalomyelitis, indicating that ICOS has a protective role in inflammatory autoimmune diseases.

摘要

T淋巴细胞的激活和免疫功能受共刺激分子调控。CD28是B7基因产物的受体,在启动T细胞免疫反应中起主要作用。CTLA4与B7的亲和力更高,在T细胞激活后被诱导产生,并参与下调T细胞反应。诱导性共刺激分子(ICOS)是CD28/CTLA4家族的第三个成员,在活化的T细胞上表达。其配体B7H/B7RP-1在动物注射脂多糖后在B细胞和非免疫组织中表达。为了解ICOS在T细胞激活和功能中的作用,我们构建并分析了ICOS缺陷小鼠。我们在此表明,在没有ICOS的情况下,T细胞激活和增殖存在缺陷。此外,ICOS -/- T细胞在体外分化或体内启动时无法产生白细胞介素-4。用多种抗原免疫后,体液免疫反应需要ICOS。ICOS-/-小鼠对实验性自身免疫性脑脊髓炎的易感性大大增强,表明ICOS在炎症性自身免疫疾病中具有保护作用。

相似文献

1
ICOS co-stimulatory receptor is essential for T-cell activation and function.诱导性共刺激分子(ICOS)共刺激受体对T细胞活化和功能至关重要。
Nature. 2001 Jan 4;409(6816):97-101. doi: 10.1038/35051100.
2
ICOS is essential for effective T-helper-cell responses.诱导性共刺激分子(ICOS)对于有效的辅助性T细胞反应至关重要。
Nature. 2001 Jan 4;409(6816):105-9. doi: 10.1038/35051113.
3
T-cell co-stimulation through B7RP-1 and ICOS.通过B7RP-1和ICOS进行T细胞共刺激。
Nature. 1999 Dec 16;402(6763):827-32. doi: 10.1038/45582.
4
ICOS is critical for CD40-mediated antibody class switching.诱导共刺激分子(ICOS)对于CD40介导的抗体类别转换至关重要。
Nature. 2001 Jan 4;409(6816):102-5. doi: 10.1038/35051107.
5
Regulation of immune and autoimmune responses by ICOS.诱导共刺激分子对免疫和自身免疫反应的调节
J Autoimmun. 2003 Nov;21(3):255-60. doi: 10.1016/s0896-8411(03)00119-7.
6
B7h is required for T cell activation, differentiation, and effector function.B7h是T细胞激活、分化和效应功能所必需的。
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14163-8. doi: 10.1073/pnas.2335041100. Epub 2003 Nov 13.
7
CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.CD4+ICOS+ T淋巴细胞在体外抑制T细胞活化,在体内减轻自身免疫性脑脊髓炎。
Int Immunol. 2008 Apr;20(4):577-89. doi: 10.1093/intimm/dxn016. Epub 2008 Feb 28.
8
Regulation of immune and autoimmune responses by ICOS-B7h interaction.通过诱导共刺激分子(ICOS)与B7h相互作用对免疫和自身免疫反应的调节
Clin Immunol. 2005 Apr;115(1):19-25. doi: 10.1016/j.clim.2005.02.010.
9
ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells.ICOS和CD28在成熟树突状细胞重新激活人效应T细胞时对白细胞介素-10进行反向调节。
Eur J Immunol. 2002 Sep;32(9):2680-6. doi: 10.1002/1521-4141(200209)32:9<2680::AID-IMMU2680>3.0.CO;2-6.
10
Identification and characterization of rat AILIM/ICOS, a novel T-cell costimulatory molecule, related to the CD28/CTLA4 family.大鼠AILIM/ICOS的鉴定与特性分析,AILIM/ICOS是一种与CD28/CTLA4家族相关的新型T细胞共刺激分子。
Biochem Biophys Res Commun. 2000 Sep 16;276(1):335-45. doi: 10.1006/bbrc.2000.3466.

引用本文的文献

1
Rapid adaptation to a globally introduced virulent pathogen in a keystone species.关键物种对全球引入的致病性病原体的快速适应。
PNAS Nexus. 2025 Jul 8;4(7):pgaf199. doi: 10.1093/pnasnexus/pgaf199. eCollection 2025 Jul.
2
PD-1 expressing islet-specific CD4 T cells promote bystander tolerance and prevent autoimmunity.表达PD-1的胰岛特异性CD4 T细胞促进旁观者耐受并预防自身免疫。
Immunol Cell Biol. 2025 Aug;103(7):738-751. doi: 10.1111/imcb.70044. Epub 2025 Jul 7.
3
Influence of polyfunctional Tbet T cells on specific clinical events in chronic lymphocytic leukaemia.
多功能Tbet T细胞对慢性淋巴细胞白血病特定临床事件的影响。
Front Immunol. 2025 Apr 17;16:1528405. doi: 10.3389/fimmu.2025.1528405. eCollection 2025.
4
Immune Tolerance Regulation Is Critical to Immune Homeostasis.免疫耐受调节对免疫稳态至关重要。
J Immunol Res. 2025 Jan 7;2025:5006201. doi: 10.1155/jimr/5006201. eCollection 2025.
5
Progress and prospects of the combination of BMI1-targeted therapy and immunotherapy in cervical cancer.BMI1靶向治疗与免疫治疗联合应用于宫颈癌的研究进展与展望
Am J Cancer Res. 2025 Jan 15;15(1):217-232. doi: 10.62347/QTWJ8918. eCollection 2025.
6
Leveraging mesoporous silica nanomaterial for optimal immunotherapeutics against cancer.利用介孔二氧化硅纳米材料实现针对癌症的最佳免疫疗法。
In Vitro Model. 2023 Nov 13;2(5):153-169. doi: 10.1007/s44164-023-00061-0. eCollection 2023 Nov.
7
Combination adjuvant improves influenza virus immunity by downregulation of immune homeostasis genes in lymphocytes.联合佐剂通过下调淋巴细胞中免疫稳态基因来提高流感病毒免疫力。
Immunohorizons. 2025 Jan 24;9(2). doi: 10.1093/immhor/vlae007.
8
Trabectedin Enhances the Antitumor Effects of IL-12 in Triple-Negative Breast Cancer.曲贝替定增强白细胞介素-12在三阴性乳腺癌中的抗肿瘤作用。
Cancer Immunol Res. 2025 Apr 2;13(4):560-576. doi: 10.1158/2326-6066.CIR-24-0775.
9
Efficacy of radiotherapy combined with atezolizumab or docetaxel in patients with previously treated NSCLC.放疗联合阿替利珠单抗或多西他赛治疗既往治疗过的非小细胞肺癌患者的疗效
iScience. 2024 Nov 8;27(12):111363. doi: 10.1016/j.isci.2024.111363. eCollection 2024 Dec 20.
10
Superior antitumor immune response achieved with proton over photon immunoradiotherapy is amplified by the nanoradioenhancer NBTXR3.纳米放射增强剂NBTXR3增强了质子免疫放射疗法相对于光子免疫放射疗法所实现的卓越抗肿瘤免疫反应。
J Nanobiotechnology. 2024 Oct 1;22(1):597. doi: 10.1186/s12951-024-02855-0.